Since the 90s, Matrixyl® has set the standard in cosmetic peptides. Croda now unveils a high-performance next generation powered by advanced encapsulation: Matrixyl® Neolide™, engineered to precisely deliver Matrixyl® into the skin and maintain activity over time.
Why encapsulate a proven iconic matrikine? Delivery remains a challenge, both in the formulations and in the skin. This technology protects Matrixyl® in formulation and enables controlled, prolonged skin release, turning a high-performing peptide into an even more reliable action system.
BETTER: smarter delivery system brands can rely on.
Encapsulation helps reduce “formulation noise” and preserve the peptide’s potency, resulting in performance that is less formulation dependent.
FASTER: performance consumers will talk about.
Clinical studies show visible benefits in as little as 2 weeks (+25 % skin firmness, p<0.01 vs T0), making it ideal for brands seeking a premium consumer experience that delivers rapid results without the hype.
STRONGER: synergistic effect aligned with beauty routine trends.
Ex vivo, Matrixyl® Neolide™ showed a clear microneedling-boosted response using a superficial, non-invasive dermaroller, supporting professional protocols and post-treatment skin care.
In a new market of delivery claims, from “drones” to liposomes, Croda’s approach is simple and effective: protect the peptide, optimise its bioavailability over time and deliver measurable skin benefits.
Designed for modern skin care, the capsules disperse seamlessly in conventional emulsion systems, promoting elegant textures. Use Matrixyl® Neolide™ in a peptide hero serum, a longevity face powder, a cellular beauty cream, or a “prep + recover” routine around aesthetic procedures, while leveraging the trusted, proven reputation of Matrixyl®.
Croda GmbH
Dr. Larissa Legewie
Technical Marketing Manager
Herrenpfad-Süd 33
41334 Nettetal
Germany
E-Mail: Larissa.Legewie@croda.com
Website: www.crodabeauty.com
